Back to results
US 8,026,365 B2Granted
4,4-disubstituted piperidine derivatives
AssigneeHoffman-La Roche Inc.
InventorsAndreas Christ, Rainer Martin, Peter Mohr
Life of this patent
Estimating the term…
Abstract
This invention relates to 4,4-disubstituted piperidine derivatives of the formula wherein A and R1 to R5 are as defined in the specification, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.
Claims13
A compound, of formula I:
- wherein
- R′ is selected from the group consisting of C2-7-alkyl, C2-7-alkenyl, C3-7-alkinyl, C3-7-cycloalkyl, halogen-C1-7-alkyl, C1-7-alkoxy-C1-7-alkyl and benzyl;
- R2 is selected from the group consisting of hydrogen, C1-7-alkyl,
- hydrogen, C1-7-alkyxy, C2-7-alkenyloxy,
- hydroxy-C1-7-alkoxy, C1-7-alkoxy-C1-7-alkoxy,
- —O-benzyl, —O—C3-7-cycloalkyl,
- halogen, halogen-C1-7-alkyl, halogen-C1-7-alkoxy,
- amino, pyrrolyl, imidazolyl,
- —C(O)OR6, wherein R6 is C1-7-alkyl, and
- unsubstituted phenyl or phenyl substituted by one to three groups independently selected from C1-7-alkyl, halogen and C1-7-alkoxy;
- R3 is hydrogen or C1-7-alkoxy;
- R4 and R5 are bonded to each other to form a ring together with the carbon atom to which they are attached, and R4 and R5 together are:
- —NH—C(O)—NH—C(O)—,
- and pharmaceutically acceptable salts thereof.
11 more elements
Dependencies are inferred from the claim text.